Phase I LITESPARK-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort
- Resource Type
- Article
- Source
- In
European Journal of Cancer January 2024 196 - Subject
UO - Language
- ISSN
- 0959-8049